Olink Holding AB (OLK)
23.94
-0.01
(-0.04%)
USD |
NASDAQ |
May 17, 16:00
23.94
0.00 (0.00%)
After-Hours: 20:00
Olink Gross Profit Margin (Quarterly): 60.68% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 60.68% |
December 31, 2023 | 71.00% |
September 30, 2023 | 69.96% |
June 30, 2023 | 58.74% |
March 31, 2023 | 64.15% |
December 31, 2022 | 74.50% |
September 30, 2022 | 66.06% |
June 30, 2022 | 62.04% |
March 31, 2022 | 58.72% |
Date | Value |
---|---|
December 31, 2021 | 57.92% |
September 30, 2021 | 62.13% |
June 30, 2021 | 67.08% |
March 31, 2021 | 63.34% |
December 31, 2020 | 68.97% |
September 30, 2020 | 71.09% |
June 30, 2020 | 70.94% |
March 31, 2020 | 55.63% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
55.63%
Minimum
Mar 2020
74.50%
Maximum
Dec 2022
64.88%
Average
64.15%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
Thermo Fisher Scientific Inc | 40.65% |
Abliva AB | -- |
Karolinska Development AB | -- |
Calliditas Therapeutics AB | 95.06% |
Oncopeptides AB | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -7.01% |
Return on Assets | -6.04% |
Return on Invested Capital | -6.98% |
Profit Margin (Quarterly) | -55.87% |
Operating Margin (Quarterly) | -86.75% |
Return on Net Operating Assets | -6.27% |